Scientists discuss in 'Individually-tailored, Internet-based treatment for anxiety disorders: A randomized controlled trial' new findings in Clinical Trials Research. According to recent research from Sweden, "Previous studies on Internet-based treatment with minimal to moderate therapist guidance have shown promising results for a number of specific diagnoses. The aim of this study was to test a new approach to Internet treatment that involves tailoring the treatment according to the patient's unique characteristics and comorbidities."
"A total of 54 participants, regardless of specific anxiety diagnosis, were included after an in-person, semi-structured diagnostic interview and randomized to a 10 week treatment program or to a control group. Treatment consisted of a number of individually-prescribed modules in conjunction with online therapist guidance. Significant results were found for all dependent measures both immediately following treatment and at 1 and 2 year intervals. Mean between-group effect size including measures of anxiety, depression and quality of life was Cohen's d=0.69 at post-treatment, while the mean within-group effect size was d=1.15 at post-treatment and d=1.13 and d=1.04 at 1 and 2 year follow-up respectively," wrote P. Carlbring and colleagues, Umea University, Department of Psychology (see also Clinical Trials Research).
The researchers concluded: "The tentative conclusion drawn from these results is that tailoring the Internet-based therapy can be a feasible approach in the treatment of anxiety in a homogeneous population."
Carlbring and colleagues published their study in Behaviour Research and Therapy (Individually-tailored, Internet-based treatment for anxiety disorders: A randomized controlled trial. Behaviour Research and Therapy, 2011;49(1):18-24).
For additional information, contact P. Carlbring, Umea University, Dept. of Psychology, Sweden.
Keywords: Country:Sweden, Anxiety Disorders, Clinical Trial Research, Clinical Trials Research, Therapy, Treatment.
This article was prepared by Clinical Trials Week editors from staff and other reports. Copyright 2011, Clinical Trials Week via NewsRx.com.

No comments:
Post a Comment